TUBB2A Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q13885 |
---|---|
Clone Names | 100427162 |
Peptide ID | 100427162 |
Gene ID | 7280 |
---|---|
Other Names | Tubulin beta-2A chain, Tubulin beta class IIa, TUBB2A, TUBB2 |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13739b was selected from the C-term region of TUBB2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TUBB2A |
---|---|
Synonyms | TUBB2 |
Function | Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain (By similarity). |
Cellular Location | Cytoplasm, cytoskeleton. |
Tissue Location | High expression in brain, where it represents 30% of all beta-tubulins. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abgent.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha-chain (By similarity).
References
Martins-de-Souza, D., et al. J Psychiatr Res 44(14):989-991(2010)Frum, R., et al. J. Proteome Res. 6(4):1410-1417(2007)Yeh, T.S., et al. Cancer Res. 64(22):8334-8340(2004)Okai, T., et al. J. Cell. Sci. 117 (PT 20), 4705-4715 (2004) :Jin, J., et al. Curr. Biol. 14(16):1436-1450(2004)

If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.